Clinical Trials Logo

Clinical Trial Summary

Expeditious, safe extubation is vitally important in the care of Intensive Care Unit (ICU) patients, as prolonged mechanical ventilation harms patients and failed extubation (i.e. re-intubation within 48 hrs) is associated with increased morbidity, mortality and costs. The urgent need to improve extubation failure is further highlighted by current observations suggesting that COVID-19 patients are at increased risk of both early and late extubation failure. The investigators previously found that decreased respiratory rate variability (indicative of reduced adaptability and/or increased stress) during Spontaneous Breathing Trials (SBTs) predicted extubation failure and outperformed the best available predictive indices. Combining this predictive analytic with standardized extubation readiness checklists and risk mitigation strategies, the investigators created the Extubation Advisor (EA). The investigators recently completed a single-center phase I mixed methods observational study (n=117) wherein there was demonstrated technical feasibility (i.e. ability to generate 92% EA of reports) and clinician acceptance of the EA tool. In the current open-label, multi-center interventional phase I study, the investigators will assess the feasibility and initial perceptions of EA implementation in the intensive care unit by (1) evaluating the feasibility of patient enrolment, data collection, and EA report generation, and (2) performing a mixed-methods analysis of critical care physician and respiratory therapist perceptions of EA. Findings from this study will inform a future randomized controlled trial assessing EA outcomes compared to standard of care, with the intent of aiding bedside decision-making, enhancing care delivery, and improving outcomes in critically ill patients with and without COVID-19.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04708509
Study type Interventional
Source Ottawa Hospital Research Institute
Contact Andrew JE Seely, MD, PhD, FRCSC
Phone 613-737-8899
Email aseely@toh.ca
Status Recruiting
Phase Phase 1
Start date October 4, 2021
Completion date February 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05114551 - ICU Predictive Score of WEaning Success in Patients At Risk of Extubation Failure
Recruiting NCT06154811 - Exploring the Use of Pulse Tissue Doppler in Predicting Extubation Success in Mechanically Ventilated Patients
Recruiting NCT06110390 - High-flow Nasal Oxygen Therapy to Prevent Extubation Failure in Adult Trauma Intensive Care Patients N/A
Completed NCT04356625 - Maximum Expiratory Pressure in Induced Cough as a Predictor of Extubation Failure N/A
Not yet recruiting NCT05506904 - Liberation From Mechanical Ventilation Using Extubation Advisor Decision Support Phase 1
Recruiting NCT05999526 - Mechanical Ventilation Reconnection for One Hour After Spontaneous Breathing Trial N/A
Completed NCT02799056 - Diaphragmatic and Pulmonary US for Extubation Success Prediction
Not yet recruiting NCT04266535 - TCI vs Manually Controlled Infusion of Propofol
Enrolling by invitation NCT05523479 - The Maximizing Extubation Outcomes Through Educational and Organizational Research (METEOR) Trial N/A
Completed NCT01513772 - The Effect of Dexmedetomidine on the Emergence Agitation in Nasal Surgery N/A
Completed NCT03495947 - High Flow Nasal Cannula in Immediately Post Extubation
Recruiting NCT03946371 - Relation Between the Volume of Subglottic Secretion and Risk of Extubation Failure in ICU Patients (SEGEX)
Recruiting NCT05356299 - Analysis of the Magnetic Tape Bandage on Respiratory Functional Effects. N/A